Management of Perioperative Pain Using Erector Spinae Plane Block in Open Microscopic Lumbar Surgery
- Conditions
- Lumbar Spine Disease
- Interventions
- Procedure: Skin infiltration LAProcedure: Erector spinae plane block
- Registration Number
- NCT06270654
- Lead Sponsor
- University of Malaya
- Brief Summary
The aim of this study is to compare patients receiving bilateral erector spinae block with ropivacaine vs control group in terms of pain score, total opioid consumption, hemodynamic changes intraoperatively, length of hospitalisation , time to ambulation post surgery and quality of recovery.
- Detailed Description
Most open spine surgery exacts a high degree of postsurgical pain due to the incision and muscle dissection of the vertebra. The postoperative pain control and early mobilization improve the quality of the surgical care. Inadequate pain relief might result in perioperative morbidity, resulting in prolonged hospital stays.
Erector spinae plane block (ESPB) is an interfascial plane block where local anaesthetic is injected in a plane preferably below the erector spinae muscle. It can provide thoracic, abdominal, and even some lower extremity analgesia. It was also theorised that erector spinae plane block can reduce opioid use and provide analgesia for lumbar surgery. The financial cost that is saved by reducing the length of hospital stay, perioperative morbidity will warrant the use of erector spinae plane block in patients undergoing lumbar spine surgery.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 40
- Age 18-75
- Patients with Glasgow Coma Scale of 15.
- American Society of Anaesthesiologists (ASA) Physical Status Classification I - II patients
- Scheduled for elective, open microscopic lumbar surgery (less than 3 levels) under general anesthesia.
- Cognitive impairment
- Patient refusal
- Weight<50kg, >120kg
- Allergy to local anesthesia
- Alcohol/ drug abuse
- Renal failure or liver failure
- Coagulopathy/thrombocytopenia
- Chronic pain with chronic opioid usage
- Ischemic heart disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Control group Skin infiltration LA Pre incision of 0.375% ropivacaine 10ml local infiltration will be given. Ropivacaine group Erector spinae plane block Bilateral erector spinae plane block (0.375% 20ml ropivacaine on each side + adrenaline 1:200,000) pre incision.
- Primary Outcome Measures
Name Time Method Pain score at recovery, 30mins, 1, 2, 4, 8,12, 24 hours post-surgery 24 hours Measure by numerical rating scale (minimum 1-least pain, maximum 10-most painful)
Total opioid consumption intraoperative 48 hours Measure by total dose consumed (in milligram)
Total opioid consumption post-operative up to 72 hours Measure by total dose consumed (in milligram)
Timing of first rescue dose of iv morphine up to 24 hours Post operation till time requiring first dose of iv morphine
- Secondary Outcome Measures
Name Time Method The quality of recovery score (QoR)-15 questionnaire at 24 hours post-operation 24 hours Measure by the quality of recovery score (QoR)-15 questionnaire (minimum of 0,maximum of 150,higher score means a better outcome)
Length of hospital stays up to 1 week Days of stay in hospital
Time to ambulation after surgery up to 1 week Time from operation till ambulation
Hemodynamic changes intraoperative Intraoperative period heart rate (heart rate measure via heart beats per minute/ECG)
Trial Locations
- Locations (1)
Universiti Malaya Medical Centre
🇲🇾Kuala Lumpur, Wilayah Persekutuan, Malaysia